Adaptive immune system

The adaptive immune system, also called the acquired or specific immune system, is a vital part of vertebrate biology. It consists of specialized cells, organs, and complex processes designed to eliminate specific pathogens. While the innate immune system provides a broad, pre-programmed response to many types of invaders, the adaptive system is highly specific. It recognizes the unique details of each particular pathogen it encounters. This precision allows the body to create immunological memory. This memory ensures that if the same pathogen returns, the body can mount an even faster and stronger response.

At the heart of this system are lymphocytes, which are specialized white blood cells. There are two primary types: B cells and T cells. B cells are responsible for humoral immunity, which involves the production of antibodies. These antibodies are proteins known as immunoglobulins. They travel through the bloodstream to bind to a foreign antigen, which is any substance that triggers an immune response. Once bound, the antibody inactivates the antigen so it cannot harm the host. T cells carry out cell-mediated immunity. This involves direct action against infected or damaged cells.

The mechanism of activation begins with antigen presentation. When a pathogen evades the innate system, it generates antigens and "danger" signals. Professional antigen-presenting cells (APCs), such as dendritic cells, macrophages, and B cells, detect these signals. Dendritic cells often engulf exogenous pathogens like bacteria or parasites in the tissues. They then migrate to lymph nodes, where they mature and communicate with T cells. During this journey, they use enzymes to chop the pathogen into smaller pieces. These pieces are displayed on the cell surface using a receptor called the Major Histocompatibility Complex (MHC).

Different types of T cells respond to different types of antigens. Exogenous antigens, which come from outside the cells, are typically displayed on MHC class II molecules. These molecules activate CD4+ T helper cells. In contrast, endogenous antigens are produced inside a host cell, such as during a viral infection. The host cell displays these internal pieces on MHC class I molecules. This process activates CD8+ cytotoxic T-cells. These "killer" cells are trained to induce death in cells that are infected by viruses or are otherwise dysfunctional. Once a cytotoxic T-cell is activated, it undergoes clonal selection to produce an army of effector cells.

The incredible variety of the adaptive immune system comes from unique genetic processes. To create millions of different receptors, lymphocytes use V(D)J recombination. This process randomly selects one variable (V), one diversity (D), and one joining (J) region from genetic segments. It discards the rest to create a unique combination for each lymphocyte. Additionally, a process called somatic hypermutation occurs. This involves accelerated random genetic mutations in antibody-coding genes to create even more specific antibodies. Because these rearrangements change the DNA, all offspring of that cell, including memory B and T cells, inherit the same specificity.

History shows how our understanding of these terms has evolved. The term "adaptive" was first used by Robert A. Good in 1964. He used it to describe antibody responses in frogs as a synonym for "acquired immune response." For decades, the term was used primarily by a small group of immunologists. However, its use exploded in the 1990s alongside the term "innate immunity." This growth coincided with the discovery of the Toll receptor system in *Drosophila*. Today, most textbooks use "adaptive" almost exclusively, though some scientists note the term can be problematic because immune responses can sometimes be maladaptive, such as in the case of allergies.

The scale of this system within the human body is massive. Humans possess approximately 2 trillion lymphocytes, which make up 20% to 40% of all white blood cells. The total mass of these cells is comparable to the human brain or liver. Interestingly, only about 2% of these cells circulate in the bloodstream at any time. The remaining 98% reside within tissues and the lymphatic system, including the spleen and lymph nodes. About 1% to 2% of the lymphocyte pool recirculates every hour. This constant movement increases the chance that a lymphocyte will encounter its matching antigen. This system provides long-lasting protection, sometimes for a lifetime, which is the fundamental principle behind vaccination.